Stay updated with breaking news from Brian Goff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Profund Advisors LLC reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 23.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,116 shares of the biopharmaceutical company’s stock after selling 7,028 shares during the quarter. Profund […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report)’s stock price was up 9% during mid-day trading on Thursday . The company traded as high as $29.22 and last traded at $29.22. Approximately 362,598 shares changed hands during trading, a decline of 57% from the average daily volume of 840,643 shares. The stock had previously closed […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript February 15, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all […]
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]